For the Inventor, By the Inventor

Enter assignee name

Gyeonggi-do, South Korea

Daewoong Co., Ltd.

USPTO Granted Patents = 14

% Expired Patents = 7.1

EPO Patents = 10

Trademarks = 8

Forward Citations = 48

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Kyoung-Yun Kim (5 out of 5 patents)

Hye-Young Sul (5 out of 5 patents)

Kyoung-Min Min (4 out of 4 patents)

4. Seung Kook Park (3 out of 13 patents)

5. Chae Ha Yoon (2 out of 2 patents)

6. Sang Kil Lee (2 out of 8 patents)

7. Chung Sei Kim (2 out of 3 patents)

8. Hyeona Yim (1 out of 3 patents)

9. Cheong-Sei Kim (1 out of 1 patent)

10. Ji-Hoon Jung (1 out of 16 patents)

11. Jae Young Chang (1 out of 2 patents)

12. Sang-Wook Lee (1 out of 32 patents)

13. Yo Kyung Chung (1 out of 5 patents)

14. Sang-Kil Lee (1 out of 12 patents)

15. Hee-Chul Chang (1 out of 3 patents)

14 patents: Sort by Forward Citations

1. 11185503 - Stable liquid composition comprising botulinum toxin (2021-11-30),

2. 10619143 - Method and producing botulinum toxin (2020-04-14),

3. 10465179 - Medium composition for preparing botulinum toxin (2019-11-05),

4. 10308923 - Medium composition for preparing botulinum toxin (2019-06-04),

5. 10117927 - Medium composition for preparing botulinum toxin (2018-11-06),

6. 9926549 - Medium composition for preparing botulinum toxin (2018-03-27),

7. 9918937 - Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract (2018-03-20),

8. 9540378 - Composition comprising purine derivatives or salt thereof for preventing or treating atopic dermatitis (2017-01-10),

9. 9512418 - Method for production of botulinum toxin (2016-12-06),

10. 9199965 - Benzoimidazole derivatives and pharmaceutical composition comprising the same (2015-12-01),

11. 9155697 - Stable liquid compositions for treating stomatitis comprising epidermal growth factor (2015-10-13),

12. 8685440 - Nanoliposome using esterified lecithin and method for preparing the same, and composition for preventing or treating skin diseases comprising the same (2014-04-01),

13. 8409586 - Stable liquid formulation of human growth hormone (2013-04-02),

14. 7811786 - Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor (2010-10-12),

Company Overview

Daewoong Co., Ltd. is a prominent South Korean company based in Gyeonggi-do, specializing in the development and manufacturing of pharmaceuticals and biopharmaceuticals. The organization focuses on innovative drug discovery and the production of high-quality medicines, catering to both domestic and international markets. With a strong commitment to research and development, Daewoong is actively involved in advancing therapeutic solutions across various medical fields, including gastroenterology, neurology, and endocrinology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#57 in Gyeonggi-do

#826 in South Korea

#42,290 in the World

Gyeonggi-do, South Korea

Daewoong Co., Ltd.

Forward Citations = 48

56 inventors:

Kyoung-Yun Kim (5 out of 5 patents)

Hye-Young Sul (5 out of 5 patents)

Kyoung-Min Min (4 out of 4 patents)

4. Seung Kook Park (3 out of 13 patents)

5. Chae Ha Yoon (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Daewoong Co., Ltd.. Retrieved from https://idiyas.com/company/daewoong-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…